Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Atefeh Khodakarami

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Biochemistry. Biokhimiia|April 9, 2021
Enhanced Solubility and One-Step Purification of Functional Dimeric Carboxypeptidase G2Atefeh Khodakarami, Bahareh Dabirmanesh, Sedigheh Asad, et al.
IUBMB Life|July 18, 2022
The role of SF3B1 and NOTCH1 in the pathogenesis of leukemiaShiva Abolhasani, Seyyed Sina Hejazian, Vahid Karpisheh, et al.
International Journal of Biological Macromolecules|February 10, 2018
Rational design toward developing a more efficient laccase: Catalytic efficiency and selectivityAtefeh Khodakarami, Negar Goodarzi, Mahshideh Hoseinzadehdehkordi, et al.
BMC Cancer|September 26, 2025
The concurrent silencing of Tim-3 and STAT-3 promotes tumor regression both in vitro and in ovoReza Karami, Shahla Khodayari, Farzaneh Eshaghi, et al.
Cancer Cell International|July 29, 2022
The molecular biology and therapeutic potential of Nrf2 in leukemiaAtefeh Khodakarami, Sara Adibfar, Vahid Karpisheh, et al.
Expert Opinion on Therapeutic Targets|January 23, 2023
The prognostic and therapeutic potentials of CTLA-4 in hematological malignanciesMohammad Sadeghi, Atefeh Khodakarami, Armin Ahmadi, et al.
Cancer Cell International|June 25, 2024
The sensitivity of acute myeloid leukemia cells to cytarabine is increased by suppressing the expression of Heme oxygenase-1 and hypoxia-inducible factor 1-alphaMohammad Sadeghi, Asma Moslehi, Hadiseh Kheiry, et al.
Cancer Cell International|March 20, 2025
Advancing the therapeutic effectiveness of paclitaxel in chronic lymphocytic leukemia through the simultaneous inhibition of NOTCH1 and SF3B1Shiva Abolhasani, Armin Mahmoud Salehi Khesht, Atefeh Khodakarami, et al.
Cell Communication and Signaling : CCS|August 1, 2023
Targeted Silencing of NRF2 by rituximab-conjugated nanoparticles increases the sensitivity of chronic lymphoblastic leukemia cells to CyclophosphamideAtefeh Khodakarami, Mahsa Afsari Kashani, Atefeh Nazer, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Biochemistry. Biokhimiia|April 9, 2021
Enhanced Solubility and One-Step Purification of Functional Dimeric Carboxypeptidase G2Atefeh Khodakarami, Bahareh Dabirmanesh, Sedigheh Asad, et al.
IUBMB Life|July 18, 2022
The role of SF3B1 and NOTCH1 in the pathogenesis of leukemiaShiva Abolhasani, Seyyed Sina Hejazian, Vahid Karpisheh, et al.
International Journal of Biological Macromolecules|February 10, 2018
Rational design toward developing a more efficient laccase: Catalytic efficiency and selectivityAtefeh Khodakarami, Negar Goodarzi, Mahshideh Hoseinzadehdehkordi, et al.
BMC Cancer|September 26, 2025
The concurrent silencing of Tim-3 and STAT-3 promotes tumor regression both in vitro and in ovoReza Karami, Shahla Khodayari, Farzaneh Eshaghi, et al.
Cancer Cell International|July 29, 2022
The molecular biology and therapeutic potential of Nrf2 in leukemiaAtefeh Khodakarami, Sara Adibfar, Vahid Karpisheh, et al.
Expert Opinion on Therapeutic Targets|January 23, 2023
The prognostic and therapeutic potentials of CTLA-4 in hematological malignanciesMohammad Sadeghi, Atefeh Khodakarami, Armin Ahmadi, et al.
Cancer Cell International|June 25, 2024
The sensitivity of acute myeloid leukemia cells to cytarabine is increased by suppressing the expression of Heme oxygenase-1 and hypoxia-inducible factor 1-alphaMohammad Sadeghi, Asma Moslehi, Hadiseh Kheiry, et al.
Cancer Cell International|March 20, 2025
Advancing the therapeutic effectiveness of paclitaxel in chronic lymphocytic leukemia through the simultaneous inhibition of NOTCH1 and SF3B1Shiva Abolhasani, Armin Mahmoud Salehi Khesht, Atefeh Khodakarami, et al.
Cell Communication and Signaling : CCS|August 1, 2023
Targeted Silencing of NRF2 by rituximab-conjugated nanoparticles increases the sensitivity of chronic lymphoblastic leukemia cells to CyclophosphamideAtefeh Khodakarami, Mahsa Afsari Kashani, Atefeh Nazer, et al.
Pageof 1